1,666 results match your criteria Gastrinoma


The Neuroendocrine Neoplasms of the Digestive Tract: Diagnosis, Treatment and Nutrition.

Nutrients 2020 May 15;12(5). Epub 2020 May 15.

Department of Human Nutrition and Metabolomic, Pomeranian Medical University in Szczecin, Broniewskiego 24 str, 71-460 Szczecin, Poland.

Nuroendocrine neoplasms (NENs) are a group of rare neoplasms originating from dispersed neuroendocrine cells, mainly of the digestive and respiratory tract, showing characteristic histology and immunoprofile contributing to classification of NENs. Some NENs have the ability to produce biogenic amines and peptide hormones, which may be associated with clinical syndromes like, e.g. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/nu12051437DOI Listing

Primary lymph node gastrinoma: a case report and review of the literature.

World J Surg Oncol 2020 Apr 28;18(1):80. Epub 2020 Apr 28.

National Institute of Gastroenterology "S. de Bellis", Research Hospital Castellana Grotte Bari, Via Turi 27, 70013 Castellana Grotte (Ba), Bari, Italy.

Background: Gastrinoma is a rare form of neuroendocrine neoplasm. The presence of a primary lymph node localization of gastrinoma is a much debated and controversial topic in the literature, as regards whether these cases represent metastatic disease from an as yet unidentified primary tumor, or the de novo occurrence of a gastrinoma in a lymph node.

Case Presentation: We report the case of a 24-year-old male with intense epigastric pain treated at the beginning with high dose proton pump inhibitors. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12957-020-01860-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7189517PMC

Cytopathological evaluation of potential malignancy of duodenal gastrinoma using aspiration smears from two patients' resected tumors (NET G1, NET G2): A case report.

Mol Clin Oncol 2020 Jun 10;12(6):592-596. Epub 2020 Apr 10.

Department of Pathology, Amagasaki Chuo Hospital, Amagasaki, Hyogo 661-0976, Japan.

Sporadic gastrin-producing neuroendocrine tumors (NETs) of the duodenum present with either Zollinger-Ellison syndrome or unspecific syndromes. Ki-67 scoring in cytopathology is an alternative approach for establishing the gastrinoma grade. Although the majority of NETs, including gastrinomas, occur in the duodenum, most research regarding the Ki-67 index is focused on tumors of pancreatic origin. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/mco.2020.2030DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7179385PMC

[Clinical features and prognostic factors of primary gastric neuroendocrine neoplasms].

Zhonghua Nei Ke Za Zhi 2020 Apr;59(4):297-302

Department of Gastroenterology, The First Affiliated Hospital with Nanjing Medical University, Nanjing 210029,China.

To study the clinical characteristics and classification of gastric neuroendocrine neoplasm(NEN) and prognostic factors of mixed adenoneuroendocrine carcinoma (MANEC) and gastric neuroendocrine carcinoma(NEC). A total of 148 gastric NENs were divided into type Ⅰ, type Ⅱ and type Ⅲ based on the classification of European Neuroendocrine Tumor Society (ENETS). Kaplan-Meier test and Cox regression model were used in univariate and multivariate survival analysis in 108 cases with pathological G3 gastric NEN. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3760/cma.j.cn112138-20190705-00474DOI Listing

p.L105Vfs mutation in a family with thymic neuroendocrine tumor combined with MEN1: a case report.

BMC Neurol 2020 Mar 4;20(1):76. Epub 2020 Mar 4.

Department of Medical Oncology, Jinhua Hospital, Zhejiang University School of Medicine, 351 Mingyue Road, Jinhua, 321000, Zhejiang Province, China.

Background: Multiple endocrine neoplasia type 1 (MEN1) is a rare autosomal dominant disorder arising from mutations of the MEN1 tumor suppressor gene on chromosome 11q13; MEN1 is characterized by the development of neuroendocrine tumors, including those of the parathyroid, gastrointestinal endocrine tissue and anterior pituitary. Additionally, thymic neuroendocrine tumors in MEN1 are also rarely reported.

Case Presentation: This case report observed a family that presented with MEN1 p. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12883-020-01659-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7055077PMC

Neuroendocrine tumors of the gastrointestinal tract and pancreas: Is it also a challenge for pediatricians?

Adv Clin Exp Med 2020 Feb;29(2):265-270

Department and Clinic of Pediatrics, Gastroenterology and Nutrition, Wroclaw Medical University, Poland.

Neuroendocrine tumors (NET) of the gastrointestinal tract and pancreas are extremely rare in the pediatric population and limited data is available. In most cases, NET of the gastrointestinal tract in children are located in the appendix. Pancreatic NET are a small but partially distinct group of the gastrointestinal neuroendocrine neoplasms. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.17219/acem/111806DOI Listing
February 2020

The Relationship of Gastrinoma in MEN 1 to Helicobacter pylori infection.

J Clin Endocrinol Metab 2020 Mar;105(3)

Department of Diabetes and Endocrinology, Royal Hobart Hospital.

Context: Helicobacter pylori and Multiple Endocrine Neoplasia Type 1 (MEN 1) are risk factors for hypergastrinemia. Gastrin-secreting neoplasms of the foregut mucosa are both a source of, and potentially stimulated by, hypergastrinemia.

Objective: To determine the relationship between H pylori exposure and the prevalence and severity of hypergastrinemia in patients with MEN 1. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/clinem/dgaa004DOI Listing

Gastrinoma in multiple endocrine neoplasia type 1 after total pancreatectomy: A case report.

Medicine (Baltimore) 2019 Dec;98(50):e18275

Outpatient Department, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China.

Rationale: Surgery for patients with multiple endocrine neoplasia type 1(MEN-1) related gastrinoma remains controversial and total pancreatectomy (TP) has rarely been performed. We reported a case of patient with MEN-1 related gastrinoma treated by TP.

Patient Concerns: A 46-year-old female was admitted to our hospital due to abdominal distension and diarrhea for 2 years. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000018275DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6922403PMC
December 2019

[Neuroendocrine tumors in daily gastroenterology and endoscopy - a practice manual].

Z Gastroenterol 2019 Dec 11;57(12):1493-1513. Epub 2019 Dec 11.

Klinische Abteilung für Gastroenterologie und Hepatologie, Medizinische Universität Wien, Universitätsklinik für Innere Medizin III, Wien, Austria.

Neuroendocrine tumors of the gastrointestinal tract (GI-NET) are rare tumors. Functional tumors with hormonal syndromes (e. g. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/a-1013-4279DOI Listing
December 2019

Case report: optimal tumor cytoreduction and octreotide with durable disease control in a patient with MEN-1 and Zollinger-Ellison syndrome-over a decade of follow-up.

World J Surg Oncol 2019 Dec 9;17(1):213. Epub 2019 Dec 9.

Department of Surgery, Drexel University College of Medicine, 245 N. 15th Street, Suite 7150, Philadelphia, PA, 19102, USA.

Background: Zollinger-Ellison syndrome (ZES) is a rare condition characterized by hypersecretion of gastrin by gastrinoma tumors leading to severe peptic ulcer disease with potential development of gastric carcinoid tumors. Herein, we report the clinical course of a 68-year-old patient with multiple endocrine neoplasia type 1 (MEN-1) who underwent several surgeries to ultimately undergo optimal tumor cytoreduction of locally advanced gastrinomas and symptomatic gastric carcinoids. The patient was subsequently maintained on octreotide long-acting release (LAR). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12957-019-1758-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6902565PMC
December 2019

Diagnostic accuracy of selective arterial calcium injection test for localization of gastrinoma.

Endocr J 2020 Mar 7;67(3):305-315. Epub 2019 Dec 7.

Department of Molecular Endocrinology and Metabolism, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.

The appropriate localization of gastrinoma is still difficult. We aimed to evaluate the diagnostic accuracy of selective arterial calcium injection (SACI) for localization of gastrinomas including multiple lesions. This retrospective study included ten patients with surgically proven gastrinomas (gastrinoma group) and six patients without any findings suggesting Zollinger-Ellison syndrome (non-gastrinoma group). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1507/endocrj.EJ19-0413DOI Listing

The Pancreatic Endocrine Tumors - Experience of First Surgical Clinic Iasi.

Chirurgia (Bucur) 2019 Sept-Oct;114(5):639-649

Pancreatic neuroendocrine tumors (PNETs) are rare and characterized by widely variable clinical presentation and often challenging surgical management. Retrospective study conducted during the last 15 years at the First Surgical Clinic of the Iasi St Spiridon University Hospital, and which included all the patients diagnosed with pancreatic endocrine tumors by immunohistochemistry. There were 26 cases diagnosed with PNET. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21614/chirurgia.114.5.639DOI Listing
November 2019
1 Read

Insights into Effects/Risks of Chronic Hypergastrinemia and Lifelong PPI Treatment in Man Based on Studies of Patients with Zollinger-Ellison Syndrome.

Int J Mol Sci 2019 Oct 16;20(20). Epub 2019 Oct 16.

Digestive Diseases Branch, NIDDK, NIH, Bethesda, MD 20892-1804, USA.

The use of proton pump inhibitors (PPIs) over the last 30 years has rapidly increased both in the United States and worldwide. PPIs are not only very widely used both for approved indications (peptic ulcer disease, gastroesophageal reflux disease (GERD), Helicobacter pylori eradication regimens, stress ulcer prevention), but are also one of the most frequently off-label used drugs (25-70% of total). An increasing number of patients with moderate to advanced gastroesophageal reflux disease are remaining on PPI indefinitely. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/ijms20205128DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6829234PMC
October 2019
1 Read

Surgical management of Zollinger-Ellison syndrome: Classical considerations and current controversies.

World J Gastroenterol 2019 Aug;25(32):4673-4681

Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences/Peking Union Medical College, Beijing 100730, China.

Zollinger-Ellison syndrome (ZES) is characterized by gastric acid hypersecretion causing severe recurrent acid-related peptic disease. Excessive secretion of gastrin can now be effectively controlled with powerful proton pump inhibitors, but surgical management to control gastrinoma itself remains controversial. Based on a thorough literature review, we design a surgical algorithm for ZES and list some significant consensus findings and recommendations: (1) For sporadic ZES, surgery should be routinely undertaken as early as possible not only for patients with a precisely localized diagnosis but also for those with negative imaging findings. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3748/wjg.v25.i32.4673DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718045PMC
August 2019
4 Reads

Contemporary surgical management of the Zollinger-Ellison syndrome in multiple endocrine neoplasia type 1.

Best Pract Res Clin Endocrinol Metab 2019 10 31;33(5):101318. Epub 2019 Aug 31.

Department of Visceral, Thoracic, and Vascular Surgery, Philipps University Marburg, Baldingerstr, 35037 Marburg, Germany.

About 30% of patients with MEN1 develop a Zollinger-Ellison syndrome. Meanwhile it is well established that the causative gastrinomas are almost exclusively localized in the duodenum and not in the pancreas, MEN1 gastrinomas occur multicentric and are associated with hyperplastic gastrin cell lesions and tiny gastrin-producing micro tumors in contrast to sporadic duodenal gastrinomas. Regardless of the high prevalence of early lymphatic metastases, the survival is generally good with an aggressive course of disease in only about 20% of patients. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beem.2019.101318DOI Listing
October 2019
2 Reads

Prognostic factors and survival in MEN1 patients with gastrinomas: Results from the DutchMEN study group (DMSG).

J Surg Oncol 2019 Nov 10;120(6):966-975. Epub 2019 Aug 10.

Department of Endocrine Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.

Background And Objectives: Gastrinomas are the most prevalent functioning neuroendocrine tumors (NET) in multiple endocrine neoplasia type 1 (MEN1). Guidelines suggest medical therapy in most patients, but surgery may be considered in a subgroup. Currently, factors to guide management are necessary. Read More

View Article

Download full-text PDF

Source
https://onlinelibrary.wiley.com/doi/abs/10.1002/jso.25667
Publisher Site
http://dx.doi.org/10.1002/jso.25667DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852496PMC
November 2019
5 Reads

[Duodenal neuroendocrine tumors].

Khirurgiia (Mosk) 2019 (7):87-95

Sechenov First Moscow State Medical University of Ministry of Health of Russia, Moscow, Russia.

Significant augmentation of the incidence of duodenal neuroendocrine tumors duodenum has been observed in recent decades. There are 5 histological types of these tumors: gastrinoma (50-60%), somatostatin-producing tumor (15%), inactive serotonin-containing tumors (20%), poorly differentiated neuroendocrine carcinoma (<3%) and gangliocytic paraganglioma (<2%). The majority of tumors are localized within the bulb and postbulbar part of duodenum, 20% are found in periampular area. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.17116/hirurgia201907187DOI Listing
September 2019

Multiple endocrine neoplasia type 1 in Poland: a two-centre experience.

Endokrynol Pol 2019 5;70(5):385-391. Epub 2019 Jul 5.

Department of Internal Diseases and Endocrinology, Medical University of Warsaw, Warsaw, Poland.

Introduction: Multiple endocrine neoplasia type 1 (MEN1) has been causing problems for clinicians since it was first described in 1954 by Wermer. Not only its rarity, but also its variable clinical manifestations and lack of genotype-phenotype correlation make it hard to establish evidence-based guidelines for the management of this syndrome. Nationwide registers and population-based research are the best means to improve knowledge about this rare disease. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5603/EP.a2019.0031DOI Listing
July 2019
5 Reads

Invited Commentary.

Ann Surg 2019 08;270(2):e22

Medical College of Wisconsin, Milwaukee, Wisconsin, The Ohio State University, Columbus, OH.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/SLA.0000000000003378DOI Listing
August 2019
1 Read

The Gastrinoma Saga Before Zollinger and Ellison: The Strøm Case Revisited.

Ann Surg 2019 08;270(2):e19-e21

Department of Clinical Medicine, University of Bergen, Bergen, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/SLA.0000000000003261DOI Listing
August 2019
2 Reads

Dehydrocostus lactone inhibits gastrinoma cancer cell growth through apoptosis induction, sub-G1 cell cycle arrest, DNA damage and loss of mitochondrial membrane potential.

Arch Med Sci 2019 May 2;15(3):765-773. Epub 2018 Feb 2.

Department of Surgical Oncology, Tangshan Worker's Hospital, Tangshan, China.

Introduction: The purpose of the present study was to evaluate the antiproliferative activity of dehydrocostus lactone against human BON-1 cancer cell lines and to explore the possible underlying mechanism.

Material And Methods: MTT cell viability assay was used to determine cytotoxic effects of dehydrocostus lactone in BON-1 cells. Fluorescence and transmission electron microscopic (TEM) techniques were used to study the effect of the compound on cellular morphology and apoptosis. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5114/aoms.2018.73128DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6524172PMC
May 2019
3 Reads

Gastroenteropancreatic neuroendocrine tumors: Role of surgery.

Authors:
Alain Sauvanet

Ann Endocrinol (Paris) 2019 Jun 11;80(3):175-181. Epub 2019 Apr 11.

Department of HPB surgery, pôle des maladies de l'appareil digestif (PMAD), université Paris Diderot, hôpital Beaujon, AP-HP, 100, boulevard du Général-Leclerc, 92110 Clichy, France. Electronic address:

Natural history of gastroenteropancreatic (GEP) Neuroendocrine tumors (NETs) is better and better known so indications of surgery are presently selective. Surgical resection, but also endoscopic resection and observation, can be proposed for gastric NETs according to presentation, size and grade. For small bowel NETs, resection is frequently needed but should obtain the best compromise between radicality and postoperative functional disorders. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ando.2019.04.009DOI Listing
June 2019
4 Reads

Clinicopathological characteristics and risk factors for recurrence of well-differentiated pancreatic neuroendocrine tumors after radical surgery: a case-control study.

World J Surg Oncol 2019 Apr 11;17(1):66. Epub 2019 Apr 11.

Department of Integrative Oncology, China-Japan Friendship Hospital, 2 Yinghuadong Road, Chaoyang District, Beijing, 100029, China.

Background: Well-differentiated pancreatic neuroendocrine tumors (PanNETs) usually have a good prognosis; however, there are patients that experience recurrence after curative resection.

Aim: To explore recurrence-related risk factors by analyzing clinicopathological data of PanNETs after radical surgery.

Methods: Clinical and pathological data from 47 patients with well-differentiated PanNETs at China-Japan Friendship Hospital from January 2012 to March 2016 were analyzed retrospectively. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12957-019-1606-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6460793PMC
April 2019
15 Reads

Imaging of Pancreatic-Neuroendocrine Tumours: An Outline of Conventional Radiological Techniques.

Curr Radiopharm 2019 ;12(2):135-155

Hammersmith Hospital, Imperial College Healthcare NHS Trust, London W12 0HS, United Kingdom.

Introduction: Pancreatic Neuroendocrine Tumours (p-NETs) are an important disease entity and comprise of peptide-secreting tumours often with a functional syndrome. Accounting for a small percentage of all pancreatic tumours, they have a good overall survival rate when diagnosed early, with surgery being curative. The role of nuclear medicine in the diagnosis and treatment of these tumours is evident. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/1874471012666190214165845DOI Listing
February 2020
5 Reads

[Primary lymph node gastrinoma].

Authors:
H Dralle

Chirurg 2019 Mar;90(Suppl 2):100

Sektion Endokrine Chirurgie, Klinik für Allgemein‑, Viszeral- und Transplantationschirurgie, Universitätsklinikum Essen, Hufelandstr. 55, 45147, Essen, Deutschland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00104-019-0886-4DOI Listing
March 2019
1 Read

Classical features of Zollinger-Ellison syndrome, in images.

Gastrointest Endosc 2019 06 5;89(6):1255-1257. Epub 2019 Feb 5.

Department of Gastroenterology and Advanced Endoscopy, Western Regional Medical Center, Cancer Treatment Centers of America, Goodyear, Arizona, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.gie.2019.01.026DOI Listing
June 2019
18 Reads

Gastric carcinoids: Does type of surgery or tumor affect survival?

Am J Surg 2019 05 28;217(5):937-942. Epub 2018 Dec 28.

Digestive Disease Institute, Virginia Mason Medical Center, Seattle, WA, USA. Electronic address:

Background: Gastric carcinoids are rare neuroendocrine tumors of the gastrointestinal tract. They are typically managed according to their etiology. However, there is little known about the impact of surgical strategy on the long-term outcomes of these patients. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjsurg.2018.12.057DOI Listing
May 2019
9 Reads

Metastatic Potential and Survival of Duodenal and Pancreatic Tumors in Multiple Endocrine Neoplasia Type 1: A GTE and AFCE Cohort Study (Groupe d'étude des Tumeurs Endocrines and Association Francophone de Chirurgie Endocrinienne).

Ann Surg 2018 Dec 21. Epub 2018 Dec 21.

INSERM, U1231, Epidemiology and Clinical Research in Digestive Cancers Team, Dijon, France.

Objective: To assess the distant metastatic potential of duodeno-pancreatic neuroendocrine tumors (DP-NETs) in patients with MEN1, according to functional status and size.

Summary Background Data: DP-NETs, with their numerous lesions and endocrine secretion-related symptoms, continue to be a medical challenge; unfortunately they can become aggressive tumors associated with distant metastasis, shortening survival. The survival of patients with large nonfunctional DP-NETs is known to be poor, but the overall contribution of DP-NETs to metastatic spread is poorly known. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/SLA.0000000000003162DOI Listing
December 2018
47 Reads
8.327 Impact Factor

Symptomatic and Radiological Response to 177Lu-DOTATATE for the Treatment of Functioning Pancreatic Neuroendocrine Tumors.

J Clin Endocrinol Metab 2019 04;104(4):1336-1344

Department of Internal Medicine, Sector of Endocrinology, Erasmus Medical Center and Erasmus MC Cancer Institute, Rotterdam, Netherlands.

Purpose: Peptide receptor radionuclide therapy (PRRT) with the radiolabeled somatostatin analogue [Lutetium-177-DOTA0-Tyr3]octreotate (177Lu-DOTATATE) is widely applied for inoperable metastatic small intestinal and nonfunctioning pancreatic neuroendocrine tumors (pNETs). The aim of this study is to describe the safety and efficacy of the treatment of functioning pNETs.

Methods: Patients were treated with up to four cycles of 177Lu-DOTATATE with an intended dose of 7. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jc.2018-01991DOI Listing
April 2019
43 Reads

Gastric Neuroendocrine Tumor and Duodenal Gastrinoma With Chronic Autoimmune Atrophic Gastritis.

Pancreas 2019 01;48(1):131-134

Division of Gastroenterology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York.

Our group observed the first case of synchronous gastric neuroendocrine tumor (NET) and duodenal gastrinoma with autoimmune chronic atrophic gastritis (CAG), in the absence of Helicobacter pylori infection. Demographic, clinical, endoscopic, and pathologic data were abstracted from the electronic medical record at Mount Sinai Hospital from 2013 to 2015. The patient's anonymity was carefully protected, and informed consent was obtained for publication of protected health information. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MPA.0000000000001204DOI Listing
January 2019
11 Reads

The impact of failure to achieve symptom control after resection of functional neuroendocrine tumors: An 8-institution study from the US Neuroendocrine Tumor Study Group.

J Surg Oncol 2019 Jan 27;119(1):5-11. Epub 2018 Nov 27.

Division of Surgical Oncology, Department of Surgery, Winship Cancer Institute, Emory University, Atlanta, Georgia.

Background: The goals of resection of functional neuroendocrine tumors (NETs) are two-fold: Oncological benefit and symptom control. The interaction between the two is not well understood.

Methods: All patients with functional NETs of the pancreas, duodenum, and ampulla who underwent curative-intent resection between 2000 and 2016 were identified. Read More

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/jso.25306
Publisher Site
http://dx.doi.org/10.1002/jso.25306DOI Listing
January 2019
18 Reads

Sporadic pancreatic neuroendocrine tumor: Surgery of the primary tumor.

J Visc Surg 2018 Dec 15;155(6):483-492. Epub 2018 Nov 15.

Service de chirurgie generale, digestive et endocrinienne, hôpital Robert-Debré, université de Reims Champagne-Ardenne, 51100 Reims, France. Electronic address:

The management of patients with sporadic pancreatic neuroendocrine tumors (PNET) is multi-disciplinary and often, multimodal. Surgery has a large part in treatment because it is the only potentially curative therapeutic modality if resection can be complete. The update reviews the operative indications and the different surgical techniques available (including parenchymal-sparing surgery) to treat the primary lesion according to patient status, preoperative work-up and whether the tumor is functioning or not. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S18787886183012
Publisher Site
http://dx.doi.org/10.1016/j.jviscsurg.2018.08.010DOI Listing
December 2018
14 Reads

Management of Primary Lymph Nodal Gastrinoma With Liver Metastases Resulting in Zollinger-Ellison Syndrome.

Clin Nucl Med 2019 Jan;44(1):e36-e39

From the Departments of Nuclear Medicine.

Primary lymph node gastrinoma has been defined as gastrin-producing tumor present in lymph nodes and predominantly found in well-defined anatomical region known as gastrinoma triangle. They are usually localized preoperatively with imaging, and their surgical resection results in long-term relief. The authors report a case of unresectable primary lymph nodal gastrinoma with liver metastases in a 14-year-old adolescent boy with proven histopathology detected on Ga-DOTANOC whole-body PET/CT scan followed by preoperative multiple Lu-DOTATATE cycles for cytoreduction. Read More

View Article

Download full-text PDF

Source
http://Insights.ovid.com/crossref?an=00003072-900000000-9736
Publisher Site
http://dx.doi.org/10.1097/RLU.0000000000002368DOI Listing
January 2019
41 Reads
3.931 Impact Factor

A rare cause of upper gastrointestinal bleeding: Primary gastrinoma of the lesser omentum.

Presse Med 2018 10 22;47(10):913-915. Epub 2018 Oct 22.

University of Tunis el Manar, La Rabta University Hospital of Tunis, Department of Gastroenetrology A, Tunis, Tunisia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lpm.2018.08.013DOI Listing
October 2018
46 Reads

Gastrinoma of Cystic Duct: A Rare Association With Multiple Endocrine Neoplasia Type 1.

J Clin Med Res 2018 Nov 9;10(11):843-847. Epub 2018 Oct 9.

Department of Internal Medicine and Endocrine Unit, Medical School and Clementino Fraga Filho University Hospital, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.

Neuroendocrine tumors (NETs) of cystic duct are extremely rare, accounting for less than 2% of NET cases. The association of biliary tree NET and multiple endocrine neoplasm type 1 (MEN1) are even more rare. In this report, we described a case of a 65-year-old woman who was referred to our neuroendocrine outpatient clinic to investigate MEN1 after an incidental diagnosis of gastrinoma. Read More

View Article

Download full-text PDF

Source
http://www.jocmr.org/index.php/JOCMR/article/view/3541
Publisher Site
http://dx.doi.org/10.14740/jocmr3541wDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6188020PMC
November 2018
48 Reads

Prognostic relevance of proliferation-related miRNAs in pancreatic neuroendocrine neoplasms

Eur J Endocrinol 2018 10 1;179(4):219-228. Epub 2018 Oct 1.

‘Lendület’ Hereditary Endocrine Tumours Research Group, Hungarian Academy of Sciences – Semmelweis University, Budapest, Hungary

Objective: Pancreatic neuroendocrine neoplasms (PanNENs) are rare tumors arising from the endocrine pancreas; however, their prognosis differs significantly upon their proliferative state, which is characterized by histopathological grading. MiRNAs are small, noncoding RNAs posttranscriptionally regulating gene expression. Our aim was to identify miRNAs with altered expression upon proliferation which can be used as prognostic biomarkers in PanNENs. Read More

View Article

Download full-text PDF

Source
https://eje.bioscientifica.com/view/journals/eje/179/4/EJE-1
Publisher Site
http://dx.doi.org/10.1530/EJE-18-0305DOI Listing
October 2018
21 Reads

Surgical procedure for multifocal duodenopancreatic gastrinomas in a MEN-1 patient (with video).

J Visc Surg 2019 Feb 27;156(1):69-71. Epub 2018 Sep 27.

Department of Digestive and Endocrine Surgery, université Paris Descartes, Cochin Hospital, Assistance publique-Hôpitaux de Paris, 27, rue du Faubourg Saint-Jacques, 75014 Paris, France; Université Paris Descartes, Paris, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jviscsurg.2018.09.005DOI Listing
February 2019
2 Reads

Multiple Endocrine Neoplasia Type 1: A Case Report With Review of Imaging Findings.

Ochsner J 2018 ;18(2):170-175

Department of Radiology, Ochsner Clinic Foundation, New Orleans, LA.

Background: Multiple endocrine neoplasia type 1 (MEN1) is a rare, autosomal dominant inherited syndrome caused by mutations in the MEN1 tumor suppressor gene. The diagnosis is defined clinically by the presence of 2 or more primary MEN1 tumors (parathyroid, anterior pituitary, and pancreatic islet). We describe the case of a patient who presented with classic history and imaging findings for MEN1. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.31486/toj.17.0019DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6135292PMC
January 2018
16 Reads

Gastric Carcinoids.

Endocrinol Metab Clin North Am 2018 09 11;47(3):645-660. Epub 2018 Jul 11.

1st Department of Propaedeutic Internal Medicine, National and Kapodistrian University of Athens, Mikras Asias 75, Athens 11527, Greece. Electronic address:

Gastric carcinoids, formally named gastric neuroendocrine neoplasms (NENs), are derived from enterochromaffin-like cells of the stomach and are increasingly diagnosed. A majority are designated as type I (related to autoimmune gastritis) and type II (related to gastrinoma) neoplasms that develop secondary to gastrin hypersecretion. Types I and II gastric carcinoids are mostly small-sized (1-2 cm), multiple, low-malignancy potential lesions mainly confined to the gastric mucosa/submucosa. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ecl.2018.04.013DOI Listing
September 2018
9 Reads
3.404 Impact Factor

Gastrinomas: Medical or Surgical Treatment.

Endocrinol Metab Clin North Am 2018 09;47(3):577-601

Digestive Diseases Branch, NIDDK, National Institutes of Health, Building 10, Room 9C-103, Bethesda, MD 20892-1804, USA. Electronic address:

This article reviews the role of surgical and medical management in patients with Zollinger-Ellison syndrome (ZES) due to a gastrin-secreting neuroendocrine tumor (gastrinoma). It concentrates on the status at present but also briefly reviews the changes over time in treatment approaches. Generally, surgical and medical therapy are complementary today; however, in some cases, such as patients with ZES and multiple endocrine neoplasia type 1, the treatment approach remains controversial. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ecl.2018.04.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6092039PMC
September 2018
35 Reads

A novel germline mutation at exon 10 of MEN1 gene: a clinical survey and positive genotype-phenotype analysis of a MEN1 Italian family, including monozygotic twins.

Hormones (Athens) 2018 Sep 6;17(3):427-435. Epub 2018 Aug 6.

EndOsmet Unit, Villa Donatello Private Hospital, Florence and Villalba Hospital, Bologna, Italy.

Context: Clinical phenotype variability in MEN1 syndrome exists and evidence for an established genotype-phenotype is lacking. However, a higher aggressiveness of MEN1-associated gastro-entero-pancreatic (GEP) (neuro)endocrine tumours (NETs) tumours has been reported when MEN1 gene truncating mutations are detected. We found a novel germline truncating mutation of MEN1 gene at exon 10 in a subject with an aggressive clinical behavior of GEP-NETs. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s42000-018-0044-2DOI Listing
September 2018
8 Reads

Large primary hepatic gastrinoma in young patient treated with trisegmentectomy: A case report and review of the literature.

World J Hepatol 2018 Jul;10(7):517-522

Departamento de Gastroenterologia, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo 05403, Brazil.

Primary hepatic gastrinoma is a rare disease, with fewer than 40 cases reported in the medical literature. Because it is located in an organ in which metastases are common, its diagnosis is difficult. We report a case of a 19 years old male patient with a history of gastric ulcers since the age of nine. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4254/wjh.v10.i7.517DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6068851PMC
July 2018
9 Reads

Imaging of pancreatic neuroendocrine tumors: recent advances, current status, and controversies.

Expert Rev Anticancer Ther 2018 09 17;18(9):837-860. Epub 2018 Jul 17.

b Digestive Diseases Branch , NIDDK, NIH , Bethesda , MD , USA.

Introduction: Recently, there have been a number of advances in imaging pancreatic neuroendocrine tumors (panNETs), as well as other neuroendocrine tumors (NETs), which have had a profound effect on the management and treatment of these patients, but in some cases are also associated with controversies. Areas covered: These advances are the result of numerous studies attempting to better define the roles of both cross-sectional imaging, endoscopic ultrasound, with or without fine-needle aspiration, and molecular imaging in both sporadic and inherited panNET syndromes; the increased attempt to develop imaging parameters that correlate with tumor classification or have prognostic value; the rapidly increasing use of molecular imaging in these tumors and the attempt to develop imaging parameters that correlate with treatment/outcome results. Each of these areas and the associated controversies are reviewed. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14737140.2018.1496822DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6283410PMC
September 2018
12 Reads

Incidental Detection of Parathyroid Adenoma on Somatostatin Receptor PET/CT and Incremental Role of F-Fluorocholine PET/CT in MEN1 Syndrome.

Nucl Med Mol Imaging 2018 Jun 2;52(3):238-242. Epub 2018 May 2.

1Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, 110029 India.

Multiple endocrine neoplasia type 1 (MEN1) syndrome is characterized by combined occurrence of tumors of endocrine glands including the parathyroid, the pancreatic islet cells, and the anterior pituitary gland. Parathyroid involvement is the most common manifestation and usually the first clinical involvement in MEN1 syndrome, followed by gastroentero-pancreatic neuroendocrine tumors (NETs). Here we present a case where the patient initially presented with metastatic gastric NET and a single parathyroid adenoma was detected incidentally on Ga-DOTANOC PET/CT done as part of post Lu-DOTATATE therapy (PRRT) follow-up. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13139-018-0520-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5995772PMC
June 2018
24 Reads

Bringing SASI back: Single session selective arterial secretin injection and transarterial embolization of intrahepatic pancreatic neuroendocrine metastasis in a MEN-1 patient.

Radiol Case Rep 2018 Apr 3;13(2):333-335. Epub 2018 Feb 3.

Department of Radiology, Division of Vascular and Interventional Radiology, University of Michigan Health Systems, 1500 East Medical Center Dr, Ann Arbor, MI 48109, USA.

SASI (selective arterial secretin injection) is a form of ASVS (arterial stimulation and venous sampling) used to localize pancreatic gastrinomas. This report aims to review the protocol for SASI and demonstrate its utility in localizing functional and nonfunctional gastrinomas. Even if a patient has a pancreatic mass and a laboratory profile fitting a specific endocrine syndrome, these may or may not be associated as has been previously demonstrated with adrenal vein sampling. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radcr.2018.01.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000080PMC
April 2018
20 Reads

Gastrinoma and Zollinger-Ellison syndrome in canids: a literature review and a case in a Mexican gray wolf.

J Vet Diagn Invest 2018 Jul 2;30(4):584-588. Epub 2018 Jun 2.

Animal Health Institute, Department of Pathology and Population Medicine, Midwestern University, Glendale, AZ (Struthers, Wong).

Gastrinoma, an infrequent diagnosis in middle-aged dogs, occurs with nonspecific gastrointestinal morbidity. Laboratory tests can yield a presumptive diagnosis, but definitive diagnosis depends on histopathology and immunohistochemistry. We describe a malignant pancreatic gastrinoma with lymph node metastases and corresponding Zollinger-Ellison syndrome in a Mexican gray wolf ( Canis lupus baileyi) and review this endocrine neoplasm in domestic dogs. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1040638718779638DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6505925PMC
July 2018
16 Reads

Prospective evaluation of Ga-DOTATATE PET/CT in limited disease neuroendocrine tumours and/or elevated serum neuroendocrine biomarkers.

Clin Endocrinol (Oxf) 2018 Aug 13;89(2):155-163. Epub 2018 Jun 13.

Department of Nuclear Medicine, La Timone & North University Hospital, Aix-Marseille University, Marseille, France.

Context: The Ga-labelled somatostatin analogues ( Ga-DOTA-SSAs) is becoming popular as an important diagnostic tool in neuroendocrine tumours as evidenced by a growing number of reports detailing institutional experience with various DOTA peptides. However, only few prospective studies have compared Ga-DOTA-SSAs and somatostatin receptor scintigraphy (SRS) in gastroenteropancreatic neuroendocrine tumours (GEP-NETs) and pulmonary neuroendocrine tumours.

Objective: The aim of our prospective study was to perform head-to-head comparison between Ga-DOTATATE PET/CT and standard imaging work-up (SI) that included multiphasic CT, liver MRI and SRS using single photon emission computed tomography. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/cen.13745DOI Listing
August 2018
52 Reads